Breast-SlimView
Hera-MIProduct specifications |
Information source:
Vendor
Last updated: Aug. 3, 2020 |
General | |
---|---|
Product name | Breast-SlimView |
Company | Hera-MI |
Subspeciality | Breast |
Modality | Mammography |
Disease targeted | Breast cancer |
Key-features | Images negativation, risk mapping, breast density. |
Suggested use | Before: stratifying reading process (non, single, double read) During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand) After: diagnosis verification |
Data characteristics | |
Population | Breast cancer screening population |
Input | 2D & 3D mammography, reports. |
Input format | DICOM |
Output | 2D & 3D negativated mammography, density results. |
Output format | DICOM |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application |
Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker) |
Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | 10 - 60 seconds |
Certification | |
CE
|
Certified,
Class IIa
, MDD
|
FDA
|
No or not yet |
Market presence | |
On market since | 02-2020 |
Distribution channels | |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | Pay-per-use, Subscription |
Based on | Number of users, Number of installations, Number of analyses |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |